Caffeine rush on the high street
Caffeine levels in espresso coffees purchased from coffee shops have been found to vary greatly and at well above the recommended daily allowance set by the Food Standards Agency.
Caffeine levels in espresso coffees purchased from coffee shops have been found to vary greatly and at well above the recommended daily allowance set by the Food Standards Agency.
A study conducted at the University of Glasgow used HPLC analysis of 20 commercial espresso coffees.1 They found six-fold differences in caffeine levels, a 17-fold range of caffeoylquinic acid contents and four-fold differences in the caffeoylquinic acid: caffeine ratio. These variations reflect differences in the bean composition, blending of different beans, roasting and grinding procedures and, most importantly, the amount of beans used in the coffee making process.
These variations mean that consumers, and especially those consumers at risk of toxicity, including pregnant women, children and those with liver disease, are unable to know for definite how much caffeine they are ingesting in a day.
The most caffeine in a single espresso was 322 mg, while a further three contained > 200 mg. The recommended upper limit for pregnant women is 200 mg day−1.
The study concluded that further study on this topic is needed and new data to provide informative labelling to inform the consumer of the way their coffee is being produced.
1. T.W.M. Crozier et al., Food Funct., 2012, DOI: 10.1039/c1fo10240k
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
